Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli

The effect of producing human plasminogen activator inhibitor-1 (PAI-1) on the physiology of the bacterium <I>Escherichia coli </I>has been investigated. PAI-1 belongs to the family of serine protease inhibitors. These inhibitors are distinct from others in that they contain the active s...

Full description

Bibliographic Details
Main Author: Creighton, Ruth Isobel
Published: University of Aberdeen 1998
Subjects:
612
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.245253
id ndltd-bl.uk-oai-ethos.bl.uk-245253
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-2452532015-03-19T07:45:49ZPhysiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coliCreighton, Ruth Isobel1998The effect of producing human plasminogen activator inhibitor-1 (PAI-1) on the physiology of the bacterium <I>Escherichia coli </I>has been investigated. PAI-1 belongs to the family of serine protease inhibitors. These inhibitors are distinct from others in that they contain the active site bond located on a mobile loop. A plasmid containing the <I>PAI-1 </I>gene was used to accumulate PAI-1 to 20% of the total cell protein. At least 50% of PAI-1 was accumulated as the active soluble protein. PAI-1 production has been shown to decrease the growth rate from 0.76 ± 0.038 h<SUP>-1</SUP> (n = 4) to 0.54±0.038 h<SUP>-1</SUP> (n = 4). Plasmids of similar construction producing either tumour necrosis factor α (TNFα) or an α<SUB>2</SUB>-interferon fragment [amino acids 4-155; IFN<SUB>4-155)</SUB>] caused no decrease in the growth rate. RpoS, an alternative sigma factor, was quantified by Western blotting. Cells producing PAI-1 had higher levels of RpoS than other recombinants; this was observed in both the exponential and stationary growth phases. These high levels of RpoS may be caused by the inhibition of the serine protease ClpP, or other proteases, by PAI-1. There is an accumulation of RpoS in the absence of ClpP as this protease is needed for the degradation of RpoS. No conclusive biochemical evidence was obtained to support this hypothesis. A correlation was found between possession of an intact <I>rpoS</I> gene and the specific ability to express PAI-1. N-ethylmaleimide (NEM) is a toxic electrophile to which <I>E. coli </I>cells are sensitive. On entry into the stationary phase, cells increase their expression of RpoS-dependent genes which confer resistance to NEM. The sensitivity of exponentially-growing cells to NEM is influenced by the growth rate. RpoS is more abundant at slow growth rates resulting in increased resistance to NEM. The strain producing PAI-1 was more sensitive to NEM during the exponential phase.612Human recombinant proteinsUniversity of Aberdeenhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.245253Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 612
Human recombinant proteins
spellingShingle 612
Human recombinant proteins
Creighton, Ruth Isobel
Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli
description The effect of producing human plasminogen activator inhibitor-1 (PAI-1) on the physiology of the bacterium <I>Escherichia coli </I>has been investigated. PAI-1 belongs to the family of serine protease inhibitors. These inhibitors are distinct from others in that they contain the active site bond located on a mobile loop. A plasmid containing the <I>PAI-1 </I>gene was used to accumulate PAI-1 to 20% of the total cell protein. At least 50% of PAI-1 was accumulated as the active soluble protein. PAI-1 production has been shown to decrease the growth rate from 0.76 ± 0.038 h<SUP>-1</SUP> (n = 4) to 0.54±0.038 h<SUP>-1</SUP> (n = 4). Plasmids of similar construction producing either tumour necrosis factor α (TNFα) or an α<SUB>2</SUB>-interferon fragment [amino acids 4-155; IFN<SUB>4-155)</SUB>] caused no decrease in the growth rate. RpoS, an alternative sigma factor, was quantified by Western blotting. Cells producing PAI-1 had higher levels of RpoS than other recombinants; this was observed in both the exponential and stationary growth phases. These high levels of RpoS may be caused by the inhibition of the serine protease ClpP, or other proteases, by PAI-1. There is an accumulation of RpoS in the absence of ClpP as this protease is needed for the degradation of RpoS. No conclusive biochemical evidence was obtained to support this hypothesis. A correlation was found between possession of an intact <I>rpoS</I> gene and the specific ability to express PAI-1. N-ethylmaleimide (NEM) is a toxic electrophile to which <I>E. coli </I>cells are sensitive. On entry into the stationary phase, cells increase their expression of RpoS-dependent genes which confer resistance to NEM. The sensitivity of exponentially-growing cells to NEM is influenced by the growth rate. RpoS is more abundant at slow growth rates resulting in increased resistance to NEM. The strain producing PAI-1 was more sensitive to NEM during the exponential phase.
author Creighton, Ruth Isobel
author_facet Creighton, Ruth Isobel
author_sort Creighton, Ruth Isobel
title Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli
title_short Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli
title_full Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli
title_fullStr Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli
title_full_unstemmed Physiological effects of producing plasminogen activator inhibitor-1 (PAI-1) in Escherichia coli
title_sort physiological effects of producing plasminogen activator inhibitor-1 (pai-1) in escherichia coli
publisher University of Aberdeen
publishDate 1998
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.245253
work_keys_str_mv AT creightonruthisobel physiologicaleffectsofproducingplasminogenactivatorinhibitor1pai1inescherichiacoli
_version_ 1716758892438880256